Biofil Chemicals & Pharmaceuticals Ltd.
Snapshot View

48.95 +0.95 ▲2.0%

06 October 2022, 04:01:00 PM
Volume: 2,128

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.biofilgroup.net
Market Cap 79.66 Cr.
Enterprise Value(EV) 79.98 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.45 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 108.97 Trailing Twelve Months Ending 2022-06
Industry PE 32.07 Trailing Twelve Months Ending 2022-06
Book Value / Share 10.47 Trailing Twelve Months Ending 2022-06
Price to Book Value 4.67 Calculated using Price: 48.95
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.63 Cr. 16,273,800 Shares
FaceValue 10
Company Profile
Biofil Chemicals & Pharmaceuticals established in 1985, is part of Cyano Group of Industries. The company is into manufacturing of drugs in area of anti-bacterial, analgesics/antipyretics, anti-malarial, anti-psychotics, anti asthmatic/bronchodilators, diuretics, tranquilizer/hypnotics, anti inflammatory, analgesic/antipyretics, anti inflammatory steroids and eye/ear drops

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.98%
1 Week
+3.49%
1 Month
-7.12%
3 Month
+3.27%
6 Month
-27.64%
1 Year
-22.91%
2 Year
-20.54%
5 Year
+176.55%
10 Year
+1267.32%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 13.53 13.47 13.28 18.09 3.64 3.60 8.46 8.01 4.24
Return on Capital Employed (%) 12.09 12.97 14.04 21.86 5.13 5.06 10.12 12.18 6.23
Return on Assets (%) 3.68 4.14 4.13 7.81 2.05 1.99 3.63 3.28 2.69

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 7 8 8 11 13 13 14 15 16 17
Non Curr. Liab. 0 0
Curr. Liab. 6 7 5 13 9 11 11 27 17 1
Minority Int.
Equity & Liab. 13 15 14 24 22 24 24 42 33 19
Non Curr. Assets 9 9 9 9 9 9 10 10 10 9
Curr. Assets 4 5 5 15 13 15 14 32 23 9
Misc. Exp. not W/O
Total Assets 13 15 14 24 22 24 24 42 33 19

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 7 6 13 13 12 23 30 36 22 29
Other Income 0 0 1 0 0 0 0 1 0 0
Total Income 7 6 14 14 12 23 30 37 23 29
Total Expenditure -6 -5 -12 -11 -11 -22 -28 -34 -21 -28
PBIDT 1 1 1 3 1 1 2 2 1 2
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 -1 0 0 0 -1 0 0
Exceptional Items
PAT 1 1 1 2 0 0 1 1 1 1
Adjusted EPS 0 0 0 1 0 0 1 1 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 1 0 1 1 1 0
Cash Fr. Inv. 0 0 0 0 0 0 -1 0 0 0
Cash Fr. Finan. 0 0 0 0 0 0 0 -1 -1 0
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 46.82 46.82 46.82 46.82 46.82 46.82 46.82 46.82 46.82
Public 53.18 53.18 53.18 53.18 53.18 53.18 53.18 53.18 53.18
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 01 Oct 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Submission of Voting Results and Combined Scrutinizers Report on Remote E-voting and e-voting facility during the 37th Annual General Meeting of the Company.
Fri, 30 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of Proceedings of 37th Annual General Meeting of the Company held on Friday 30th September 2022 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR) Regulations 2015
Wed, 28 Sep 2022
Closure of Trading Window
Dear Sir/Madam This is with reference to the BSE Circular Ref No. LIST/COMP/01/2019-20 and NSE Circular Ref No.NSE/CML/2019/11 dated 02.04.2019 we wish to inform you that in terms of Companys Code ofConduct to regulate monitor and report trading in Companys Securities by Insiders framed underSEBI(Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in theSecurities of Company will remain closed for all Designated Persons their immediate relatives andconnected persons (as defined in the Code) w.e.f October 1 2022 for the purpose of considerationof Un-Audited Financial Results for the half year ended September 30 2022.The Trading Window shall open 48 hours after Un-Audited Financial Results for the half year endedSeptember 30 2022 become generally availableThis is for your information and records

Technical Scans View Details >>

Tue, 04 Oct 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 954.00 +1.2%
Divi's Laboratories Ltd. 99,171.10 3,735.70 -1.2%
Cipla Ltd. 91,534.16 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. 54,354.34 1,606.00 +0.9%
Zydus Lifesciences Ltd. 42,831.42 423.15 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 36.78 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 423.15 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 4.26 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 423.15 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 423.15 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 423.15 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 423.15 +0.8%

FAQ's On Biofil Chemicals & Pharmaceuticals Ltd.

What is Biofil Chem & Pharma share price?

Can I buy Biofil Chem & Pharma shares now?

What is the Market Cap of Biofil Chem & Pharma?

What are the key metrics to analyse Biofil Chem & Pharma?

What is the 52 Week High and Low of Biofil Chem & Pharma?

What is the trend of Biofil Chem & Pharma share price?